REMDESIVIR (has an active metabolite) | REMDESIVIR | ATC J05AB16
ANTIINFECTIVES SARS-COV-2 NUCLEOTIDE ANALOG RNA POLYMERASE INHIBITOR ANTIVIRAL | INTRAVENOUS | Cmax 3.7 MICROMOLAR Tmax 0.67 HOUR PPB 90.8 PERCENT HT 1 HOUR | RNA POLYMERASE | Replicase polyprotein 1ab UNIPROT P0DTD1 REP more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |